Business

TrumpRx expands with 2 new drugmakers offering prescription drug discounts

INTERMEDIATE: The White House is expected to announce an increase in drug manufacturers offering discounts on TrumpRx.gov, FOX Business has learned.

Starting today, Amgen and GSK will be added to the list of prescription drug manufacturers offering discounts on the government website. That makes a total of 54 prescription drugs from six pharmaceutical companies that have signed up to the country’s most popular price cuts under pressure from President Donald Trump and the threat of tariffs.

Amgen will offer the drug on the website at an 80% discount on the retail price. Amjevita has an original price of $1,484, but will be available on TrumpRx.gov for $299. The drug treats rheumatoid arthritis, psoriasis and ulcerative colitis.

FOX NEWS POLL: VOTERS SOUND ALARM ON HEALTH CARE COSTS

President Donald Trump speaks as Centers for Medicare & Medicaid Services Administrator Mehmet Oz looks on during a drug pricing event in the South Court Auditorium on the White House campus February 5, 2026, in Washington, DC. (Nathan Howard/Getty Images)

The company plans to list Aimovig and Repatha for discounts of 62%.

GSK will reduce the Incree to 55% of the retail price. The drug treats COPD and will list for $159.

GSK also plans to list Arnuity, Relenza and Anoro with discounts ranging from 10% to 51%.

A ticker Security Finally Change Change %
AMGN Company AMGEN INC. 366.21 -1.58

-0.43%

GSK GSK PLC data 53.39 -0.89

-1.64%

“GSK and Amgen connecting with TrumpRx.gov to provide prescription drugs directly to consumers at affordable prices in popular countries marks another milestone in President Trump’s push,” White House spokesman Kush Desai told FOX Business.

“TrumpRx.gov is just the beginning, however, as Americans are set to (get) big drug price discounts, lower insurance premiums and more transparency when Congress passes President Trump’s Big Health Plan.”

Pharmacy techs pull medications from the shelf inside the pharmacy

Amgen will offer the drug on the website at an 80% discount on the retail price. (George Frey/Bloomberg via Getty Images)

The Pharmaceutical Research and Manufacturers of America represents the major drug companies.

CEO Stephen Ubl believes that “popular government policies will undermine US competitiveness while doing nothing to address insurance practices that deny care and increase costs for patients.

HOUSE GOP WANTS SKY-HIGH HEALTH INSURANCE COSTS FOR BILLIONS OF AMERICANS

“These policies will take billions out of American R&D, slow the pace of medicine and increase reliance on China for future innovation.”

Photo of pharmacy drugs at Walgreens.

GSK will reduce the Incree to 55% of the retail price. (Jeffrey Greenberg/Universal Images Group via Getty Images)

The White House is moving forward with announcements on TrumpRx.gov as Americans look for ways to lower medical costs.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

Under the Biden administration, data from the Bureau of Labor Statistics shows, the cost of prescription drugs increased by 10.4% from January 2021 to January 2025. Under the Trump administration, drug prices increased by 0.2% from January 2025 through the latest data from February 2026.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button